Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Virginia Commonwealth University
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
SWOG Cancer Research Network
National Cancer Institute (NCI)
European Institute of Oncology
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Baylor Breast Care Center
Northwestern University
Oslo University Hospital